Screener
AbbVie ABBV Invested capital
Discontinued — last reported Q4 '25
Invested capital at other companies
Other financials
Where this comes from
Calculated from AbbVie’s reported figures.
The source filing: AbbVie’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's invested capital?
- AbbVie (ABBV) reported invested capital of $53.87B in Q4 2025.
- How has AbbVie's invested capital changed year-over-year?
- AbbVie's invested capital decreased by 8.8% year-over-year, from $59.06B to $53.87B.
- What is the long-term trend for AbbVie's invested capital?
- Over 5 years (2020 to 2025), AbbVie's invested capital has grown at a -8.3% compound annual growth rate (CAGR), from $83.25B to $53.87B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about AbbVie's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude